Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / News / 2012 News / Wang receives grant from the Lung Cancer Research Foundation

Wang receives grant from the Lung Cancer Research Foundation

by maryruth.helms — last modified Oct 08, 2012 01:11 PM
Andrew Wang, MD, assistant professor of radiation oncology, has been awarded a $50,000 one-year grant from the Lung Cancer Research Foundation.
Wang receives grant from the Lung Cancer Research Foundation

Dr. Wang has received a grant for research into the use of nanoparticles for drug delivery of DNA double-strand break repair inhibitors.

Wang is a member of UNC Lineberger Comprehensive Cancer Center.

The grant will fund research into the use of nanoparticles for drug delivery of DNA double-strand break repair inhibitors (DSBRIs) in combined chemotherapy and radiation therapy treatment of non-small cell lung cancer. DSBRIs can sensitize cancer cells to both chemotherapy and radiation therapy, but need to be delivered selectively to cancer cells, while sparing normal cells. Dr. Wang’s lab will test nanoparticle formulations of DSBRIs and evaluate their effectiveness in laboratory models.

Filed under: , ,